Publicacións nas que colabora con Manuel F. Jiménez Navarro (13)

2023

  1. Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 548-554

2019

  1. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

2018

  1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

2017

  1. Prognostic value of body mass index in transcatheter aortic valve implantation: A “J”-shaped curve

    International Journal of Cardiology, Vol. 232, pp. 342-347

2016

  1. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623

2015

  1. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

    Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20

  2. Dual antiplatelet therapy duration after coronary stenting in clinical practice: Results of an EAPCI survey

    EuroIntervention, Vol. 11, Núm. 1, pp. 68-74

  3. Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts

    American Journal of Cardiology, Vol. 116, Núm. 11, pp. 1695-1699

2014

  1. Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 312, Núm. 10, pp. 1006-1015

  2. Erratum: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial (JAMA (2014) 312:10(1006-1015))

    JAMA - Journal of the American Medical Association

2011

  1. Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry

    Revista Espanola de Cardiologia, Vol. 64, Núm. 11, pp. 981-987

2008

  1. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 372, Núm. 9641, pp. 807-816

  2. The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - Baseline characteristics of the study population

    Cardiology (Switzerland), Vol. 110, Núm. 4, pp. 271-282